DOCK3
Summary: This gene is specifically expressed in the central nervous system (CNS). It encodes a member of the DOCK (dedicator of cytokinesis) family of guanine nucleotide exchange factors (GEFs). This protein, dedicator of cytokinesis 3 (DOCK3), is also known as modifier of cell adhesion (MOCA) and presenilin-binding protein (PBP). The DOCK3 and DOCK1, -2 and -4 share several conserved amino acids in their DHR-2 (DOCK homology region 2) domains that are required for GEF activity, and bind directly to WAVE proteins [Wiskott-Aldrich syndrome protein (WASP) family Verprolin-homologous proteins] via their DHR-1 domains. The DOCK3 induces axonal outgrowth in CNS by stimulating membrane recruitment of the WAVE complex and activating the small G protein Rac1. This gene is associated with an attention deficit hyperactivity disorder-like phenotype by a complex chromosomal rearrangement. [provided by RefSeq, Aug 2010].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
dedicator of cytokinesis 3 | MIM:603123 | Ensembl:ENSG00000088538 | HGNC:HGNC:2989 | PA27455 | 3p21.2 |
GO terms in DOCK3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IEA | GO:0007264 | small GTPase mediated signal transduction |
BP | TAS | GO:1903997 | positive regulation of non-membrane spanning protein tyrosine kinase activity |
CC | IDA | GO:0005829 | cytosol |
CC | TAS | GO:0005829 | cytosol |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0017124 | SH3 domain binding |
MF | TAS | GO:0030676 | Rac guanyl-nucleotide exchange factor activity |
Gene expression in normal tissue: DOCK3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in DOCK3
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-109582 | Hemostasis |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-166520 | Signaling by NTRKs |
reactome | R-HSA-166520 | Signaling by NTRKs |
reactome | R-HSA-9006115 | Signaling by NTRK2 (TRKB) |
reactome | R-HSA-9006115 | Signaling by NTRK2 (TRKB) |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
reactome | R-HSA-9032500 | Activated NTRK2 signals through FYN |
reactome | R-HSA-9032500 | Activated NTRK2 signals through FYN |
reactome | R-HSA-9032759 | NTRK2 activates RAC1 |
reactome | R-HSA-9032759 | NTRK2 activates RAC1 |
reactome | R-HSA-983231 | Factors involved in megakaryocyte development and platelet production |
wikipathways | WP2380 | Brain-Derived Neurotrophic Factor (BDNF) signaling pathway |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD552 | AZD-1775 | 2 |
iGMDRD300 | Tozasertib | 2 |
iGMDRD42 | Vorinostat | 3 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD871 | BRD6368 | 2 |
iGMDRD414 | MST-312 | 3 |
iGMDRD366 | PI-103 | 2 |
iGMDRD329 | Merck60 | 3 |
iGMDRD662 | JQ-1 | 1 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD77 | Itraconazole | 3 |
iGMDRD121 | GMX1778 | 3 |
iGMDRD158 | NSC141540 | 4 |
iGMDRD137 | Indisulam | 2 |
iGMDRD271 | Brefeldin A | 4 |
iGMDRD103 | SN-38 | 5 |
iGMDRD5 | Tyrphostin AG 1478 | 1 |
iGMDRD177 | Teniposide | 3 |
iGMDRD901 | ELCPK | 3 |
iGMDRD341 | Triacsin c | 2 |
iGMDRD351 | GW843682X | 2 |
iGMDRD299 | ICL 670 | 3 |
iGMDRD116 | CD437 | 1 |
iGMDRD512 | nutlin 3 | 2 |
iGMDRD584 | VER 155008 | 5 |
iGMDRD64 | Parbendazole | 1 |
iGMDRD369 | TGX-115 | 3 |
iGMDRD451 | Serdemetan | 3 |
iGMDRD23 | Gossypol | 2 |
iGMDRD356 | PNU-74654 | 3 |
iGMDRD399 | Selumetinib | 5 |
iGMDRD506 | Fedratinib | 1 |
iGMDRD577 | BIX01294 | 2 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD297 | Austocystin D | 1 |
iGMDRD446 | LY 2183240 | 1 |
iGMDRD193 | Fqi1 | 1 |
iGMDRD546 | BMS-754807 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in DOCK3